Hoodia spammer settles
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission accepts a settlement with hoodia marketers charged under the U.S. Safe Web Act with making "false and unsubstantiated" claims about their products through spam e-mails, according to a July 15 release. In an October 2007 complaint, FTC said Wyoming-based Spear Systems falsely claimed its products - falsely marketed as hoodia - enabled rapid, permanent weight loss, and the firm's promotional e-mails violated the CAN-SPAM Act by including deceptive subject lines and lacking an opt-out link (1"The Tan Sheet" Oct. 15, 2007, p. 13). Under the terms of the settlement, Spear Systems must surrender $29,000 in alleged ill-gotten gains...
You may also be interested in...
Hoodia Firm Ordered To Halt Unsubstantiated Ads In First FTC Safe Web Claim
An international spamming enterprise marketing hoodia weight-loss and human hormone anti-aging products was the first operation targeted by the Federal Trade Commission under the new U.S. Safe Web Act
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.